DuPont Grows Biotech Investment; Reaffirms Outlook

DuPont’s Applied BioSciences unit, formerly Bio-Based Materials, is expected to generate revenues of $800 million in 2010 and $2.3 billion in 2012, the company said at an investors meeting, held last week at Wilmington, DE. The company says it will invest $500 million in capital over the next three years in the unit, which comprises its biofuels, biomaterials, biospecialties, and biomedical businesses. Some $300-million of that will go toward building new biofuel facilities and pilot plants. Sustainable growth: DuPont showcases next-generation biofuels...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers